Azathioprine (usage thérapeutique) < Azithromycine (MeSH) < Azithromycine (administration et posologie)

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f Mesh.f MeshFr.f KwdFr.f

List of bibliographic references indexed by Azithromycine (MeSH)

Number of relevant bibliographic references: 49.
[0-20] [0 - 20][0 - 49][20-40]

Ident.	Authors (with country if any)	Title
000073 (2021)	Alexis Lacout [France] ; Valere Lounnas [Allemagne] ; Christian Perronne [France]	Timing and dosage may be the key in the realisation of hydroxychloroquine + azithromycin treatment benefit in Covid-19 elderly patients.
000212 (2021)	N. Dauby [Belgique] ; L. Catteau [Belgique] ; J. Hautekiet [Belgique] ; M. Montourcy [Belgique] ; E. Bottieau [Belgique] ; E. Goetghebeur [Belgique] ; D. Van Beckhoven [Belgique]	Reply to 'Low-dose hydroxychloroquine therapy and lower mortality in hospitalized patients with COVID-19: association does not mean causality'.
000235 (2021)	Bashar Fteiha [Israël] ; Hani Karameh [Israël] ; Ramzi Kurd [Israël] ; Batsheva Ziff-Werman [Israël] ; Itamar Feldman [Israël] ; Alon Bnaya [Israël] ; Sharon Einav [Israël] ; Amir Orlev [Israël] ; Eli Ben-Chetrit [Israël]	QTc prolongation among hydroxychloroquine sulphate-treated COVID-19 patients: An observational study.
000237 (2021)	Matteo Bianco [Italie] ; Carlo Alberto Biolè [Italie] ; Enrico Cerrato [Italie]	QT Interval in Patients With COVID-19.
000238 (2021)	Ingrid Berling [Australie] ; Robert S. Hoffman [États-Unis] ; Sophie Gosselin [Canada]	QT Interval in Patients With COVID-19.
000239 (2021)	Christina F. Yen [États-Unis] ; David J. Shim [États-Unis] ; Howard S. Gold [États-Unis]	QT Interval in Patients With COVID-19-Reply.
000247 (2021)	Zaki Akhtar [Royaume-Uni] ; Mark M. Gallagher [Royaume-Uni] ; Yee Guan Yap [Malaisie] ; Lisa W M. Leung [Royaume-Uni] ; Ahmed I. Elbatran [Royaume-Uni] ; Brendan Madden [Royaume-Uni] ; Victoria Ewasiuk [Royaume-Uni] ; Louise Gregory [Royaume-Uni] ; Aodhan Breathnach [Royaume-Uni] ; Zhong Chen [Royaume-Uni] ; David S. Fluck [Royaume-Uni] ; Sumeet Sharma [Royaume-Uni]	Prolonged QT predicts prognosis in COVID-19.
000350 (2021)	Shih-Chieh Shao ; Edward Chia-Cheng Lai ; Yi-Hua Chen ; Yuk-Ying Chan ; Hui-Yu Chen	Management of Irrational Self-Purchase of Hydroxychloroquine During the COVID-19 Pandemic: Experiences From the Largest Healthcare System in Taiwan.
000409 (2021)	Michael J. Keane [Australie]	Hydroxychloroquine with or without Azithromycin in Covid-19.
000410 (2021)	Rahul Choudhary [Oman] ; Gopal K. Bohra [Oman] ; Deepak Kumar [Oman]	Hydroxychloroquine with or without Azithromycin in Covid-19.
000411 (2021)	Alexandre B. Cavalcanti [Brésil] ; Otávio Berwanger [Brésil] ; Fernando G. Zampieri [Brésil]	Hydroxychloroquine with or without Azithromycin in Covid-19. Reply.
000434 (2021)	Alexis Lacout [France] ; Christian Perronne [France] ; Valere Lounnas [Allemagne]	Hydroxychloroquine in Hospitalized Patients with Covid-19.
000435 (2021)	Peter Horby [Royaume-Uni] ; Nicholas J. White [Royaume-Uni] ; Martin J. Landray [Royaume-Uni]	Hydroxychloroquine in Hospitalized Patients with Covid-19. Reply.
000564 (2021)	Mario Cazzola [Italie] ; Vito De Novellis [Italie] ; Andrea Bianco [Italie] ; Paola Rogliani [Italie] ; Maria Gabriella Matera [Italie]	Disputes over the production and dissemination of misinformation in the time of COVID-19.
000589 (2021)	Matthew P. Fox ; Lucy D'Agostino Mcgowan ; Bryan D. James ; Justin Lessler ; Shruti H. Mehta ; Eleanor J. Murray	Concerns About the Special Article on Hydroxychloroquine and Azithromycin in High-Risk Outpatients With COVID-19.
000715 (2021)	Chia Siang Kow [Malaisie] ; Syed Shahzad Hasan [Australie]	Azithromycin in patients with COVID-19: Friend or foe?
000845 (2020)	Corneliu P. Popescu [Roumanie] ; Philip R. Fischer [États-Unis]	Hydroxychloroquine-azithromycin for COVID-19 - Warranted or dangerous?
000875 (2020)	Lucie Pothen [Belgique] ; Halil Yildiz [Belgique] ; Julien De Greef [Belgique] ; Andrea Penaloza [Belgique] ; Christophe Beauloye [Belgique] ; Leila Belkhir [Belgique] ; Jean Cyr Yombi [Belgique]	Safe use of hydroxychloroquine and its combination with azithromycin in the context of Sars-CoV-2 outbreak: Clinical experience in a Belgian tertiary center.
000877 (2020)	David Lebeaux [France] ; Matthieu Revest [France]	No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: Comment on "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France".
000908 (2020)	Mariella Farfán-L Pez [Pérou] ; Abraham Espinoza-Culupú [Pérou, Brésil]
000A21 (2020)	Amir Qaseem ; Jennifer Yost ; Itziar Etxeandia-Ikobaltzeta ; Matthew C. Miller ; George M. Abraham ; Adam J. Obley ; Mary Ann Forciea ; Janet A. Jokela ; Linda L. Humphrey [États-Unis]	Update Alert: Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19? Living Practice Points From the American College of Physicians.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i -k "Azithromycine (MeSH)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i  \
                -Sk "Azithromycine (MeSH)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdFr.i
   |clé=    Azithromycine (MeSH)
}}

---

This area was generated with Dilib version V0.6.38. Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021